CBD skincare for sensitive skin: 7 checks before you buy

Regulation (EC) 1223/2009 defines a cosmetic by what it does: cleaning, perfuming, changing the appearance, protecting the skin or keeping it in good condition. Under article L5111-1 of the French Public Health Code, a product "presented as having properties for treating or preventing disease in human beings" is a medicine. It would then need a marketing authorisation.

CBD has fitted into this framework since 2021. MILDECA, France's drug policy agency, notes that pure CBD entered CosIng, the EU database of cosmetic ingredients, in February 2021. That came after the Kanavape ruling of the Court of Justice of the European Union, which our article on the Kanavape ruling covers. The CosIng entry for cannabidiol separates CBD derived from a cannabis extract, tincture or resin from synthetic CBD.

The novel food regime covers CBD that is swallowed and does not apply to a product applied to the skin. Our overview of CBD regulation in 2026 describes where ingested products stand.

Regulation (EU) 655/2013 lays down six common criteria for cosmetic claims: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. Applied to the wording on a pack, they give this:

Our article on permitted claims goes through the fine points of each wording.

The skin can react in two ways. Irritation is a direct local reaction that depends on the dose and shows up quickly. Sensitisation is an allergy: the immune system learns to recognise the substance and reacts at every new contact, sometimes after weeks of use without any trouble.

On 26 March 2026, the EU Scientific Committee on Consumer Safety (SCCS) issued its final opinion on cannabidiol (reference SCCS/1685/25). Its answers to these two questions differ:

Two studies cited in the opinion suggest a low risk at cosmetic levels. In the first, 54 volunteers applied a cream with 0.3% CBD under a repeated patch-test protocol, and none of them reacted. In the second, CBD patches at 0.1 to 10% caused no irritation or sensitisation in volunteers with healthy skin; only a hemp seed oil produced a slight reaction to light after 48 hours.

For reactive skin, the fact to remember is still the 1B classification. Someone already sensitised can react to a low concentration.

1. Check the INCI name. Ingredients are listed in INCI nomenclature, in descending order of weight, and the order is free below 1%. Look for "Cannabidiol". "Cannabis Sativa Seed Oil" is a seed oil with no significant cannabinoid content, as our article on CBD oil and hemp seed oil explains.
2. Look for the content. No rule makes it compulsory to display, but a serious seller states it in mg per container. For a cream whose density is close to 1, 95 mg in a 50 ml jar corresponds to the 0.19% benchmark, and our checklist for assessing a cream or balm sets out the calculation.
3. Watch the fragrance. The word "parfum" (or "aroma") can hide dozens of substances, including allergens that have to be named above a certain threshold. Reactive skin is better off with a fragrance-free formula; our article on fragrance allergens explains the rule.
4. Prefer a short formula, since every ingredient adds a chance of reaction. Essential oils, frequent in balms sold as natural, may contain allergens such as linalool or limonene, which the rules require to be named.
5. Check the THC. The finished product has to stay at or below 0.30% Δ⁹-THC, while the SCCS considers THC safe as a cosmetic impurity only up to 0.00025%, a benchmark 1,200 times lower. A certificate of analysis matched to the batch number lets you check the Δ⁹-THC line.
6. Read the mandatory information: the name and address of the responsible person in the EU, the batch number, the period after opening, the precautions for use and the ingredient list. Without a batch number, a reaction cannot be traced back to anything.
7. Read the claims. A product promising to act on eczema or psoriasis is breaking the law, which also tells you something about how serious its manufacturer is.

The Association française de l'eczéma, the French eczema association, suggests a simple test. Put a small amount in the crook of the elbow, if the skin there is healthy. Bend the arm without squeezing for 15 minutes, straighten it and look again 15 minutes later. Do this every day for 5 days.

Redness, tingling or itching signals poor tolerance. A negative result says nothing about the future, because a contact allergy can develop after prolonged use.

If a doctor follows you for eczema or psoriasis, ask them before putting a new product on the affected areas. Our article on CBD, eczema and psoriasis reviews the research and makes no promises.

Stop using the product at the first signs. See a doctor if the reaction spreads, persists or reaches the face.

Then report it. Since 1 January 2024, cosmetovigilance has been handled by Anses, which took it over from the ANSM. Consumers file reports on the national portal for adverse health events. Tell the responsible person whose address is on the pack as well, and give them the batch number. These reports help identify a product or an ingredient that causes problems.